Macgregor, A. H., Johnson, J. E., & Bunde, C. A. (1968). Further clinical experience with clomiphene citrate. Fertility and Sterility, 19(4), 616-622. https://doi.org/10.1016/s0015-0282(16)36736-x
Macgregor AH, Johnson JE, Bunde CA. Further clinical experience with clomiphene citrate. Fertil Steril. 1968;19(4):616-622. doi:10.1016/s0015-0282(16)36736-x
Macgregor, A. H., et al. "Further clinical experience with clomiphene citrate." Fertility and Sterility, vol. 19, no. 4, 1968, pp. 616-622.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Free to read at the publisher (reported by Unpaywall and OpenAlex, not verified by RRM Academy)
About 7 in 10 women ovulated on clomiphene in a 1968 case series
In 1968, a drug company pooled records sent in by outside doctors on thousands of women whose cycles were not releasing eggs each month. Among these women, roughly 7 in 10 began releasing eggs again after taking the fertility drug clomiphene citrate, and roughly 3 in 10 later got pregnant.
About 7 in 10 women who were not ovulating began ovulating after taking clomiphene citrate. Source: Macgregor AH et al., 1968, PMID 5660246.Study at a glance, case series of 4,098 women who were not ovulating: About 70% of women not ovulating began ovulating on clomiphene in 1968. Source: Macgregor AH et al., 1968, PMID 5660246.
Key Findings
Among 2,196 pregnancies tracked, 1,744 delivered: 1,201 single live births (1,179 survived) and 136 multiple pregnancies producing 305 infants (251 survived).
Thirty-eight birth defects, including 5 with Down syndrome, occurred among the 1,744 completed pregnancies; no clear pattern was found among the defects.
Among 4,098 women who were not ovulating, about 70% ovulated after treatment, a rate that stayed steady since the earlier report; the pregnancy rate rose slightly to 31%.
Ovulation tracked with estrogen status: 79.6% of patients with good estrogen ovulated, versus 32.0% of those with absent estrogen (2,381 and 147 patients).
Among patients who were not ovulating, conception tracked the husband's fertility: 35.6% conceived when fertile, 24.1% when borderline, and 4.3% when infertile.
Interpretation
This 1968 case series pooled clinical records submitted by outside physicians to the drug's manufacturer. Ovulation tracked with estrogen status, and conception among anovulatory women tracked the husband's fertility. The authors found no clear pattern among the recorded birth defects. The authors noted that the gap between the ovulation rate and the pregnancy rate was perplexing and called for further study of that disparity.
RRM Context
Clomiphene citrate is still used today to help women ovulate. This report shows an older approach. The authors sorted patients by diagnosis and concluded that an intact pituitary-ovarian axis is a prerequisite for the drug to work. Fewer women got pregnant than ovulated, and the authors reported multiple pregnancies up to tenfold more often in treatment cycles. Restorative reproductive medicine puts finding the cause first, ahead of simply restoring ovulation.
Our editorial summary of this paper, not the article's abstract.